AzTrials
AzTrials

StrokeNCT02066116

Kinect-based Upper Limb Rehabilitation System in Stroke Patients

A study testing Kinect-based rehabilitation plus occupational therapy in people with Stroke and Hemiplegia, run by Seoul National University Bundang Hospital at 1 site in South Korea.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The investigators have developed the kinect-based upper extremity rehabilitation program and designed this protocol to prove the efficacy of this program. In brief, subacute stroke patients allocated to intervention group will receive the kinect based-rehabilitation program plus conventional occupational therapy and… Read more about this study

Who is it for?
Ages 20 to 80 years
Conditions the study is for
Stroke, Hemiplegia, Virtual Rehabilitation
What is being tested?
Kinect-based rehabilitation plus occupational therapy
Type of treatment
Surgery or procedure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
23 participants
Where
1 siteSouth Korea
Study dates
Nov 2014to Nov 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age from 20 to 80 years
  • Stroke within prior 3 months
  • Unilateral upper extremity weakness

Who cannot join

  • Uncontrolled medical conditions
  • Who cannot obey the simple command
  • Who has the hemispatial neglect, visual impairment, apraxia

Trial locations and contacts

1 site in 1 country.

South Korea1 site
  • Seoul National University Hospital

    Seongnam-si, Gyeonggi-do, 463-707

Other trials in South Korea

About this study

Official title: Effect of Kinect-based Upper Limb Rehabilitation System in Patients With Stroke: A Pilot Trial

The investigators have developed the kinect-based upper extremity rehabilitation program and designed this protocol to prove the efficacy of this program.

In brief, subacute stroke patients allocated to intervention group will receive the kinect based-rehabilitation program plus conventional occupational therapy and patients allocated to control group will receive the sham virtual rehabilitation plus conventional occupational therapy, for 10 days.

20 patients with subacute stroke will be allocated into each group and after completing the 10 days intervention, they will be assessed by using objective assessment tools for upper extremity function.

Being tested
Kinect-based rehabilitation plus occupational therapy, sham virtual rehabilitation education plus occupational therapy
Medical subject headings
Stroke, Hemiplegia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Kinect-based rehabilitation plus occupational therapyProcedure or surgery

    The developed kinect-based rehabilitation system will be used for 30min/session. Conventional 30min occupational therapy also will be applied for the patient enrolled.

  • sham virtual rehabilitation education plus occupational therapyOther

    For the sham virtual rehabilitation, computer-based cognitive rehabilitation program will be used. Patients will be encouraged to use their affected arm to push the button but the motion will be minimal and not related to the concept of upper extremity rehabilitation.

Study groups in NCT02066116
Study groupRoleWhat they receive
Kinect-based RehabilitationExperimentalNot described
Receives: Procedure: Kinect-based rehabilitation plus occupational therapy
Self-exercises educationActive comparatorNot described
Receives: Other: sham virtual rehabilitation education plus occupational therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from Baseline in Fugl-Meyer Assessment Scale for upper extremity at 2 weeks

    Measured: Baseline, 2 weeks after the baseline

Secondary outcomes (4)
  1. Brunnstrom stage

    This is composed of 6 stages. Higher score means better function. The description for each stage as follows.

    1. Flaccidity: no voluntary movement.
    2. Synergies or minimal voluntary movement.
    3. Synergies performed voluntary (spasticity gratest).
    4. Some deviation from synergy.
    5. Independent or isolated movement.
    6. Individual joint movement nearly normal with minimal spasticity.

    Measured: Baseline, 2 weeks after the baseline, 6 weeks after the baseline, 14 weeks after the baseline

  2. Modified Barthel Index

    Measured: Baseline, 2 weeks after the baseline, 6 weeks after the baseline, 14 weeks after the baseline

  3. Box and Block Test

    Individuals are seated at a table, facing a rectangular box that is divided into two square compartments of equal dimension by means of a partition.

    One hundred and fifty, 2.5 cm, colored, wooden cubes or blocks are placed in one compartment or the other.

    The individual is instructed to move as many blocks as possible, one at a time, from one compartment to the other for a period of 60 seconds.

    The BBT is scored by counting the number of blocks carried over the partition from one compartment to the other during the one-minute trial period.

    Measured: Baseline, 2 weeks after the baseline, 6 weeks after the baseline, 14 weeks after the baseline

  4. Number of movement counts during rehabilitation using accelerometer data

    Measured: Baseline, 2 weeks after the baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Feb 2014 (estimated)
  2. Study startNov 2014
  3. Primary completionNov 2017
  4. Study completionNov 2017

Why it stopped: enrollment is difficult and pilot nature of this study

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Care provider, Outcomes assessor
Enrolment
23 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02066116
Sponsor's protocol ID
B1401-234-001
Status last verified
Nov 2017
First submitted
13 Feb 2014
Last updated
6 Nov 2017
Results posted
No
Data monitoring committee
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Kinect-based rehabilitation plus occupational therapy in people with Stroke and Hemiplegia, run by Seoul National University Bundang Hospital at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 6 Nov 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: enrollment is difficult and pilot nature of this study). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from Baseline in Fugl-Meyer Assessment Scale for upper extremity at 2 weeks (time frame: Baseline, 2 weeks after the baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Nov 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT02066116 | AzTrials